138
138
Sep 2, 2014
09/14
by
CNBC
tv
eye 138
favorite 0
quote 0
sanofi owns 20 -- >> how much do you still own?can be a french company. >> i own a fair share of the companies. >> like what? >> i don't calculate it on a daily basis. >> last time you looked? >> it was a lot. but we held on for 25 years. >> i know. i know. >> you -- >> is it bigger than a bread basket? is it double digits, above 10? >> no i mean -- >> it's good, it's good. >> a $35 billion company. len, thank you. do you own martha's vineyard or just part of it? >> we were just up there visiting. we weren't in the hamptons at the big party that you were at this weekend. >> oh, right exactly. thank you. >> great to be here. >> coming up, the plan to kill amazon. new york magazine's kevin ruse says the six strategies competitors plan to use to stake down the retail giant. we're back with that and a lot more. when change is in the air you see things in a whole new way. it's in this spirit that ing u.s. is becoming a new kind of company. one that helps you think differently about what's ahead, and what's possible when you get things o
sanofi owns 20 -- >> how much do you still own?can be a french company. >> i own a fair share of the companies. >> like what? >> i don't calculate it on a daily basis. >> last time you looked? >> it was a lot. but we held on for 25 years. >> i know. i know. >> you -- >> is it bigger than a bread basket? is it double digits, above 10? >> no i mean -- >> it's good, it's good. >> a $35 billion company. len, thank you. do you...
160
160
Sep 4, 2014
09/14
by
CNBC
tv
eye 160
favorite 0
quote 0
and sanofi is building up a 22% position in the company and i think they want to own much more. regeneron has a lot in common with a.j. they have more than doubled and green has has back-to-back seasons of double digit catches. the only thing holding a.j. back is the need for a better quarterback. get a solid arm behind him and he'll be off to the races. nothing is holding back regeneron. here's the bottom line. your fantasy football team needs good wide receivers to make the plays happen. because when things go right, the momentum names can rack up enormous names. i recommend tesla, netflix and regeneron for your real portfolio. pat in new york, pat? >> caller: hi, jim. booyah to you. >> booyah, pat. what's up? >> caller: thanks for helping us home gamers. i got your book, "get rich carefully." >> terrific. thank you so much. >> caller: jim, my stock is restoration hardware. ticker rh. restoration hardware. >> now, look, restoration hardware is a very expensive stock. we know that it has a high priced earnings multiple. we know it's reporting very soon. we had gary friedman on
and sanofi is building up a 22% position in the company and i think they want to own much more. regeneron has a lot in common with a.j. they have more than doubled and green has has back-to-back seasons of double digit catches. the only thing holding a.j. back is the need for a better quarterback. get a solid arm behind him and he'll be off to the races. nothing is holding back regeneron. here's the bottom line. your fantasy football team needs good wide receivers to make the plays happen....
136
136
Sep 25, 2014
09/14
by
CNBC
tv
eye 136
favorite 0
quote 0
and mankind which is a development deal with sanofi trying to develop a deal, dn insulin -- inhaled insulinment i'm trying to say, which would be having for interesting. so many folks with diabetes have trouble with trying to inject themselves. but that is in the development stages. >> thank you bertha. 1971.30 is the trade on the s&p 500. less than a point from session lows. dom is tracking the moves for us. >> if you look behind me right now all you see is a sea of red. as we pan out you will see about 15 to 20 actually in the green. we'll get to that in a bit but lots of red across the board. you heard bertha about san disk and biojen. like we've been saying for the bulk of this morning, it's a white spread selloff on the markets. all 10 sectors are down on the session in the s&p 500. the leading decliner has been technology. apple certainly not helping matters there. utilities, the star outperformers, if you will. just down about half a percent. and if you look at the individual stock winners and losers. on the loser side, specialty metals and the vago, a semi-conductor type company. an
and mankind which is a development deal with sanofi trying to develop a deal, dn insulin -- inhaled insulinment i'm trying to say, which would be having for interesting. so many folks with diabetes have trouble with trying to inject themselves. but that is in the development stages. >> thank you bertha. 1971.30 is the trade on the s&p 500. less than a point from session lows. dom is tracking the moves for us. >> if you look behind me right now all you see is a sea of red. as we...
216
216
Sep 2, 2014
09/14
by
CNBC
tv
eye 216
favorite 0
quote 0
and europe, while amgen and sanofi sent the stock.y're given as injections, which cause some to wonder whether patients will be as likely to take the drugs. the ceo told us that compliance was very good in the studies just reported. and behind amgen and regeneron are other drug makers, including pfizer and eli lilly. so, it's a big race for potentially a very big market. back to you guys. >> meg, thanks very much. something to keep an eye on. heading to the close, we've got 12 minutes left in the trading session. the dow's down 32 points, nasdaq is higher by about 10, oil down sharp, down 3% today, and gold just continues to tumble here. >>> norwegian cruise line's ceo is speaking with us in a first on cnbc interview. find out why he is shelling out $3 billion to buy privately held prestige cruises. stay with us. and startup ny companies will be investing hundreds of millions of dollars in jobs and infrastructure. thanks to startup ny, businesses can operate tax free for 10 years. no property tax. no business tax. and no sales tax. wh
and europe, while amgen and sanofi sent the stock.y're given as injections, which cause some to wonder whether patients will be as likely to take the drugs. the ceo told us that compliance was very good in the studies just reported. and behind amgen and regeneron are other drug makers, including pfizer and eli lilly. so, it's a big race for potentially a very big market. back to you guys. >> meg, thanks very much. something to keep an eye on. heading to the close, we've got 12 minutes...
232
232
Sep 25, 2014
09/14
by
CNBC
tv
eye 232
favorite 0
quote 0
it entered into a licensing deal with sanofi. >> i will show you.replacement for the first iphone i got, the iphone 6. this is my replacement. it just slipped right out. i was holding it with something else and it fell and shattered. >> the screen or the whole phone? >> the screen. i haven't been using it because it just shattered. there wasn't a case at the store when i went there. i'll be back at the apple store this afternoon to buy a new one. >> bertha coombs at the nasdaq, thank you. >> let's head over to chicago the bond pits and see how rick santelli is shaping up this morning. >> good morning. on the treasury side, we are looking forward to the 1:00 eastern end of the last the supply wheel which will be $29 billion seven-year notes completing $93 billion. how have the markets reacted this week? today we had weaker than expected headline month over month drop in durable goods going back to the data series creation. last month was the biggest at 22.5%. it's a mean reverting volatile series. you can than see on a two-day chart 2.57 seems to be
it entered into a licensing deal with sanofi. >> i will show you.replacement for the first iphone i got, the iphone 6. this is my replacement. it just slipped right out. i was holding it with something else and it fell and shattered. >> the screen or the whole phone? >> the screen. i haven't been using it because it just shattered. there wasn't a case at the store when i went there. i'll be back at the apple store this afternoon to buy a new one. >> bertha coombs at the...
127
127
Sep 16, 2014
09/14
by
CNBC
tv
eye 127
favorite 0
quote 0
sanofi got hurt buying all that stuff. >>> david kostin will weigh in how stocks will move after the begins raising short-term rates. back to 1983. back in a moment. know that chasing performance can mean lower returns and fewer choices in retirement. know that proper allocation could help increase returns so you can enjoy that second home sooner. know the right financial planning can help you save for college and retirement. know where you stand with pnc total insight. a new investing and banking experience with personalized guidance and online tools. visit a branch, call or go online today. big day? ah, the usual. moved some new cars. hauled a bunch of steel. kept the supermarket shelves stocked. made sure everyone got their latest gadgets. what's up for the next shift? ah, nothing much. just keeping the lights on. (laugh) nice. doing the big things that move an economy. see you tomorrow, mac. see you tomorrow, sam. just another day at norfolk southern. where the reward was that what if tnew car smelledit card and the freedom of the open road? a card that gave you that "i'm 16 and
sanofi got hurt buying all that stuff. >>> david kostin will weigh in how stocks will move after the begins raising short-term rates. back to 1983. back in a moment. know that chasing performance can mean lower returns and fewer choices in retirement. know that proper allocation could help increase returns so you can enjoy that second home sooner. know the right financial planning can help you save for college and retirement. know where you stand with pnc total insight. a new investing...